Feature Channels: Heart Disease

Filters close
access_time Embargo lifts in 2 days
Embargo will expire: 30-Mar-2020 2:00 PM EDT Released to reporters: 27-Mar-2020 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Mar-2020 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

26-Mar-2020 2:35 PM EDT
COVID-19 linked to cardiac injury, worse outcomes for patients with underlying heart conditions
University of Texas Health Science Center at Houston

COVID-19 can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying heart conditions, according to a review published today in JAMA Cardiology by experts at The University of Texas Health Science Center at Houston (UTHealth).

access_time Embargo lifts in 2 days
Embargo will expire: 31-Mar-2020 9:00 AM EDT Released to reporters: 26-Mar-2020 12:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2020 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer
Released: 26-Mar-2020 11:55 AM EDT
Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer
University of Colorado Cancer Center

University of Colorado Cancer Center group shows CPT1A may be necessary for ovarian cancer spread, chemo-resistance. Moves toward clinical trial of CPT1A inhibitor, etomoxir, against chemo-resistant ovarian cancer.

access_time Embargo lifts in 2 days
Embargo will expire: 31-Mar-2020 9:00 AM EDT Released to reporters: 26-Mar-2020 11:45 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2020 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 25-Mar-2020 4:35 PM EDT
Mayo Clinic provides urgent guidance, approach to identify patients at risk of drug-induced sudden cardiac death from use of off-label COVID-19 treatments
Mayo Clinic

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.

Newswise:Video Embedded ultrasound-solves-an-important-clinical-problem-in-diagnosing-arrhythmia
VIDEO
Released: 25-Mar-2020 2:45 PM EDT
Ultrasound Solves an Important Clinical Problem in Diagnosing Arrhythmia
Columbia University School of Engineering and Applied Science

Columbia Engineering researchers have used an ultrasound technique they pioneered a decade ago--electromechanical wave imaging (EWI)--to accurately localize atrial and ventricular cardiac arrhythmias in adult patients in a double-blinded clinical study. They evaluated the accuracy of EWI for localization of various arrhythmias in all four chambers of the heart prior to catheter ablation: the results showed that EWI correctly predicted 96% of arrhythmia locations as compared with 71% for 12-lead ECGs.

Released: 25-Mar-2020 2:05 PM EDT
Expert Alert: Have heart disease? Protect your health during the COVID-19 pandemic
Mayo Clinic

People with heart disease and other underlying health conditions are at a high risk for becoming seriously ill if they develop COVID-19. Heart patients may question if they are doing the right things for their health at a time when there is little research available surrounding this new viral disease. Stephen Kopecky, M.D., a Mayo Clinic cardiologist, talks about what heart patients need to consider in relation to COVID-19.

Released: 25-Mar-2020 1:05 PM EDT
New research predicts purified, prescription-strength fish oil could prevent more than 70,000 adverse cardiovascular events nationwide each year
University of California, Irvine

Researchers from the University of California, Irvine have conducted a statistical analysis that predicts more than 70,000 heart attacks, strokes and other adverse cardiovascular events could be prevented each year in the U.S. through the use of a highly purified fish oil therapy.

Released: 24-Mar-2020 2:05 PM EDT
Is step count associated with lower risk of death?
JAMA - Journal of the American Medical Association

Researchers looked at whether taking more steps and higher intensity stepping were associated with reduced risk of death in this observational study that included almost 4,900 adults (40 and over) who wore a device called an accelerometer to measure their step count and step intensity (steps/minute).


Showing results

110 of 10

close
1.73472